Per ulteriori informazioni selezionare i riferimenti di interesse.
Comparative analysis of micrometastasis to the bone marrow and lymph nodesof node-negative breast cancer patients receiving no adjuvant therapy
JOURNAL OF CLINICAL ONCOLOGY
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
NEW ENGLAND JOURNAL OF MEDICINE
Monoclonal antibody therapy with Edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells inbone marrow
CLINICAL CANCER RESEARCH
EVALUATION OF BONE-MARROW MICROMETASTASES AS POTENTIAL SURROGATE MARKER FOR EFFICACY OF ADJUVANT TREATMENT
European journal of cancer